Submission for OMB Review; 30-Day Comment Request; NCI Genomic Data Commons (GDC) Data Submission Request Form (National Cancer Institute), 14173-14174 [2023-04628]
Download as PDF
14173
Federal Register / Vol. 88, No. 44 / Tuesday, March 7, 2023 / Notices
Number of
respondents
Form name
Number of
responses per
respondent
Total burden
hours
Rural Health Network Development Planning Program
Performance Improvement Measurement System ..........
23
1
23
1
23
Total ..............................................................................
23
........................
23
........................
23
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: March 2, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–04621 Filed 3–6–23; 8:45 am]
BILLING CODE 4140–01–P
Maria G. Button,
Director, Executive Secretariat.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–04585 Filed 3–6–23; 8:45 am]
BILLING CODE 4165–15–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ddrumheller on DSK120RN23PROD with NOTICES1
Average
burden per
response (in
hours)
Total
responses
Name of Committee: National Institute on
Aging Special Emphasis Panel; Dementia
Care.
Date: March 28, 2023.
Time: 9:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Dario Dieguez, Ph.D.,
Scientific Review Officer, National Institutes
of Health, National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 827–3101,
dario.dieguez@nih.gov.
VerDate Sep<11>2014
19:49 Mar 06, 2023
Jkt 259001
Submission for OMB Review; 30-Day
Comment Request; NCI Genomic Data
Commons (GDC) Data Submission
Request Form (National Cancer
Institute)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Jean Claude
Zenklusen, Ph.D., Scientific Program
Director, Center for Cancer Genomics
SUMMARY:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
(CCG), National Cancer Institute,
Building 31 Room 3A20, 31 Center
Drive, Bethesda MD 20814 or call the
non-toll-free number 301–781–3409 or
Email your request, including your
address to: Jean.Zenklusen@nih.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on November 7, 2022, page
67049 (Vol. 87 No. 215 FR 67049 and
allowed 60 days for public comment. No
public comments were received. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Cancer Institute (NCI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: NCI Genomic
Data Commons (GDC) Data Submission
Request Form, 0925–0752, Expiration
Date 3/31/2023, EXTENSION, National
Cancer Institute (NCI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The purpose of the NCI
Genomic Data Commons (GDC) Data
Submission Request Form is to provide
a vehicle for investigators to request the
submission of their cancer genomic data
into the GDC in support of data sharing.
The purpose is also to provide a
mechanism for the GDC Data
Submission Review Committee to
review and assess the data submission
request for applicability to the GDC
mission. The scope of the form involves
obtaining information from investigators
that: (1) would like to submit data about
their study into the GDC, (2) are
affiliated with studies that adhere to
GDC data submission conditions. The
benefits of the collection are that it
provides the needed information for
investigators to understand the types of
E:\FR\FM\07MRN1.SGM
07MRN1
14174
Federal Register / Vol. 88, No. 44 / Tuesday, March 7, 2023 / Notices
studies and data that the GDC supports
and allows for a standard mechanism
for the GDC to assess incoming data
submission requests.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
50 hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Average time
per response
(in hours)
Total annual
burden hour
Investigator ......................................................................................................
200
1
15/60
50
Total ..........................................................................................................
........................
200
........................
50
Dated: March 2, 2023.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
[FR Doc. 2023–04628 Filed 3–6–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Center for Scientific
Review Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
register at: https://public.csr.nih.gov/
AboutCSR/Organization/
CSRAdvisoryCouncil/Registration.
The meeting can be viewed remotely
via the NIH Videocasting website:
https://videocast.nih.gov/watch=49156.
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
responses per
respondent
Name of Committee: Center for Scientific
Review Advisory Council.
Date: March 27, 2023.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: Provide advice to the Director,
Center for Scientific Review (CSR), on
matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: National Institutes of Health, 6701
Rockledge Drive, Conference Room 160A,
Bethesda, MD 20892.
Contact Person: Bruce Reed, Ph.D., Deputy
Director, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892, (301) 594–9159,
reedbr@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
VerDate Sep<11>2014
19:49 Mar 06, 2023
Jkt 259001
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
stringent procedures for entrance into NIH
federal property. Visitors will be asked to
show one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the purpose
of their visit.
Additional Health and Safety Guidance:
Before attending a meeting at an NIH facility,
it is important that visitors review the NIH
COVID–19 Safety Plan at https://
ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/Pages/default.aspx for
information about requirements and
procedures for entering NIH facilities,
especially when the COVID–19 community
level is medium. If the COVID–19 level is
high, the meeting will be held virtually. In
addition, the Safer Federal Workforce
website has FAQs for visitors at https://
www.saferfederalworkforce.gov/faq/visitors/.
Please note that if an individual has a
COVID–19 diagnosis within 10 days of the
meeting, that person must attend virtually.
(For more information please read NIH’s
Requirements for Persons after Exposure at
https://ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVID-assessmenttesting/Pages/persons-after-exposure.aspx
and What Happens When Someone Tests
Positive at https://ors.od.nih.gov/sr/dohs/
safety/NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/test-positive.aspx.)
Anyone from the public can attend the
meeting virtually via the NIH Videocasting
website (https://videocast.nih.gov). Please
continue checking these websites, in addition
to the committee website listed below, for the
most up-to-date guidance as the meeting date
approaches.
Information is also available on the
Institute’s/Center’s home page: https://
public.csr.nih.gov/AboutCSR/Organization/
CSRAdvisoryCouncil, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Dated: March 1, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–04622 Filed 3–6–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
U.S. Geological Survey
[GX23EE000101100]
Public Meeting of the National
Geospatial Advisory Committee
Department of the Interior.
Notice of public meeting.
AGENCY:
ACTION:
In accordance with the
Federal Advisory Committee Act
(FACA) of 1972, the U.S. Geological
Survey (USGS) is publishing this notice
to announce that a Federal Advisory
Committee meeting of the National
Geospatial Advisory Committee (NGAC)
will take place.
DATES: The webinar meeting will be
held on Tuesday, April 11, 2023, from
1 p.m. to 5 p.m. and on Wednesday,
April 12, 2023, from 1 p.m. to 5 p.m.
(Eastern Standard Time).
ADDRESSES: The meeting will be held
on-line and via teleconference.
Instructions for accessing the meeting
will be posted at www.fgdc.gov/ngac.
Comments can be sent by email to gsfaca@usgs.gov.
FOR FURTHER INFORMATION CONTACT: Mr.
John Mahoney, Federal Geographic Data
Committee (FGDC), USGS, by mail at
909 First Avenue, Room 703, Seattle,
WA 98104; or by email at jmahoney@
usgs.gov; or by telephone at (206) 375–
2565.
SUPPLEMENTARY INFORMATION: This
meeting is being held under the
provisions of the FACA of 1972 (5
U.S.C., Appendix 10), the Government
in the Sunshine Act of 1976 (5 U.S.C.
552B, as amended), and 41 CFR 102–
3.140 and 102–3.150.
SUMMARY:
E:\FR\FM\07MRN1.SGM
07MRN1
Agencies
[Federal Register Volume 88, Number 44 (Tuesday, March 7, 2023)]
[Notices]
[Pages 14173-14174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04628]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; NCI Genomic
Data Commons (GDC) Data Submission Request Form (National Cancer
Institute)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30 days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Jean Claude Zenklusen, Ph.D., Scientific Program
Director, Center for Cancer Genomics (CCG), National Cancer Institute,
Building 31 Room 3A20, 31 Center Drive, Bethesda MD 20814 or call the
non-toll-free number 301-781-3409 or Email your request, including your
address to: [email protected].
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on November 7, 2022, page
67049 (Vol. 87 No. 215 FR 67049 and allowed 60 days for public comment.
No public comments were received. The purpose of this notice is to
allow an additional 30 days for public comment.
The National Cancer Institute (NCI), National Institutes of Health,
may not conduct or sponsor, and the respondent is not required to
respond to, an information collection that has been extended, revised,
or implemented on or after October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: NCI Genomic Data Commons (GDC) Data Submission
Request Form, 0925-0752, Expiration Date 3/31/2023, EXTENSION, National
Cancer Institute (NCI), National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of the NCI
Genomic Data Commons (GDC) Data Submission Request Form is to provide a
vehicle for investigators to request the submission of their cancer
genomic data into the GDC in support of data sharing. The purpose is
also to provide a mechanism for the GDC Data Submission Review
Committee to review and assess the data submission request for
applicability to the GDC mission. The scope of the form involves
obtaining information from investigators that: (1) would like to submit
data about their study into the GDC, (2) are affiliated with studies
that adhere to GDC data submission conditions. The benefits of the
collection are that it provides the needed information for
investigators to understand the types of
[[Page 14174]]
studies and data that the GDC supports and allows for a standard
mechanism for the GDC to assess incoming data submission requests.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 50 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Type of respondent Number of responses per per response Total annual
respondents respondent (in hours) burden hour
----------------------------------------------------------------------------------------------------------------
Investigator.................................... 200 1 15/60 50
---------------------------------------------------------------
Total....................................... .............. 200 .............. 50
----------------------------------------------------------------------------------------------------------------
Dated: March 2, 2023.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer Institute, National
Institutes of Health.
[FR Doc. 2023-04628 Filed 3-6-23; 8:45 am]
BILLING CODE 4140-01-P